Patent ID: 7282523

Claim:
A method for the treatment of beta-Amyloid protein-induced cytotoxicity in a human brain comprising administering to a subject suffering from the beta-Amyloid protein-induced disease a therapeutically effective amount of a compound having the formula (V): or a pharmaceutically acceptable salt or ester thereof, wherein: the dotted configuration . . . is optionally a single bond or a double bond; R 10 is selected from the group consisting of OH, OMe, OR′, and X wherein R′ is alkyl, alkenyl, or alkynyl, and X is F, Cl, Br, or I; R 11 is selected from the group consisting of H, OH, OMe, and OR′ wherein R′ is alkyl, alkenyl, or alkynyl; and R 12 is selected from the group consisting of alkyl, alkenyl, and alkynyl.